Journal of Gastroenterology

, Volume 47, Issue 9, pp 969–977

Anti-high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1/HMGB2) antibodies and anti-Saccharomyces cerevisiae antibodies (ASCA): accuracy in differentially diagnosing UC and CD and correlation with inflammatory bowel disease phenotype

  • Hiromasa Takaishi
  • Takanori Kanai
  • Atsushi Nakazawa
  • Fumihiko Sugata
  • Akira Nikai
  • Shigeo Yoshizawa
  • Yasuo Hamamoto
  • Shinsuke Funakoshi
  • Tomoharu Yajima
  • Yasushi Iwao
  • Masao Takemura
  • Shoichi Ozaki
  • Toshifumi Hibi
Original Article—Alimentary Tract

DOI: 10.1007/s00535-012-0566-3

Cite this article as:
Takaishi, H., Kanai, T., Nakazawa, A. et al. J Gastroenterol (2012) 47: 969. doi:10.1007/s00535-012-0566-3

Abstract

Background

The development of a supportive diagnostic method has long been required to differentially diagnose ulcerative colitis (UC) and Crohn’s disease (CD). Several antibodies circulate in the sera of patients with inflammatory bowel disease. We previously identified the high mobility group box 1 and box 2 non-histone chromosomal proteins (HMGB1 and HMGB2) as novel antigens of perinuclear type anti-neutrophil cytoplasmic antibodies (pANCA) and discovered anti-HMGB1/HMGB2 antibodies in sera from patients with UC. Here, we evaluated the ability of anti-HMGB1/HMGB2 antibodies combined with anti-Saccharomyces cerevisiae antibodies (ASCA) to differentially diagnose UC and CD.

Methods

We measured titers of anti-HMGB1/HMGB2 antibodies and ASCA in the sera of 213 patients with UC and 93 with CD, using enzyme-linked immunosorbent assays.

Results

Among the patients with UC, 26.8% were positive for anti-HMGB1/HMGB2 antibodies, with 85.0% specificity towards CD and a positive predictive value of 80.3%. Corticosteroids significantly suppressed the titer of anti-HMGB1/HMGB2 antibodies. Among the patients with CD, 24.7% were positive for ASCA, with 96.2% specificity towards UC and a positive predictive value of 74.2%. Interestingly, the positivity rate of anti-HMGB/HMGB2 antibodies was higher (35.7%) in patients with the ileitis type of CD than in patients with CD in the colon (6.2%; significant difference, P < 0.01). The specificity of anti-HMGB1/HMGB2 antibodies in UC for CD in the colon was 93.8%.

Conclusions

CD in the colon and UC can be differentially diagnosed using anti-HMGB/HMGB2 antibodies combined with ASCA.

Keywords

Anti-high mobility group box 1 and box 2 non-histone chromosomal proteinsAnti-Saccharomyces cerevisiae antibodiesUlcerative colitisCrohn’s disease

Copyright information

© Springer 2012

Authors and Affiliations

  • Hiromasa Takaishi
    • 1
  • Takanori Kanai
    • 1
  • Atsushi Nakazawa
    • 1
  • Fumihiko Sugata
    • 2
  • Akira Nikai
    • 3
  • Shigeo Yoshizawa
    • 1
  • Yasuo Hamamoto
    • 1
  • Shinsuke Funakoshi
    • 1
  • Tomoharu Yajima
    • 1
  • Yasushi Iwao
    • 1
  • Masao Takemura
    • 4
  • Shoichi Ozaki
    • 2
  • Toshifumi Hibi
    • 1
  1. 1.Division of Gastroenterology and Hepatology, Department of Internal MedicineKeio University School of MedicineTokyoJapan
  2. 2.Division of Rheumatology and Allergy, Department of Internal MedicineSt. Marianna University School of MedicineKanagawaJapan
  3. 3.Division of Gastroenterology and Hepatology, Department of Internal MedicineSt. Marianna University School of MedicineKanagawaJapan
  4. 4.Department of Informative Clinical MedicineGifu University Graduate School of MedicineGifuJapan